KALV- Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palleiko Benjamin L	462.6K	$12.49M	-
Other	Yea Christopher	223.5K	$6.03M	-
Other	Audhya Paul K.	142.5K	$3.85M	-
Other	Arif Bilal	100.0K	$2.70M	-
Other	Sweeny Nicole	51.4K	$1.39M	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2023	Audhya Paul K.	Chief Medical Officer	Sale+OE	2,780	$10.14	$28,201.43	-17.6%	+3.7%	+14.6%
Feb 17, 2023	Audhya Paul K.	Chief Medical Officer	Sale+OE	3,412	$7.66	$26,135.92	-26.7%	+28.1%	+83.0%
Feb 17, 2023	Feener Edward P.72	Chief Scientific Officer	Sale+OE	2,228	$7.66	$17,066.48	-3.3%	+28.1%	+83.0%
Feb 17, 2023	Yea Christopher53	Chief Development Officer	Sale+OE	2,727	$7.66	$20,888.82	-7.1%	+28.1%	+83.0%
Feb 17, 2023	Palleiko Benjamin L46	President, CFO, Cbo &Sec'y	Sale+OE	4,954	$7.66	$37,947.64	-6.4%	+28.1%	+83.0%
Feb 17, 2023	Crockett Thomas Andrew72	CEO	Sale+OE	6,700	$7.66	$51,322.00	-5.2%	+28.1%	+83.0%
Nov 18, 2022	Yea Christopher53	Chief Development Officer	Sale+OE	1,139	$5.44	$6,196.16	-3.2%	+49.7%	+59.5%
Nov 18, 2022	Palleiko Benjamin L46	CFO, Cbo &Secretary	Sale+OE	722	$5.44	$3,927.68	-1.0%	+49.7%	+59.5%
Nov 18, 2022	Feener Edward P.72	Chief Scientific Officer	Sale+OE	530	$5.44	$2,883.20	-0.8%	+49.7%	+59.5%
Nov 18, 2022	Crockett Thomas Andrew72	CEO	Sale+OE	1,785	$5.44	$9,710.40	-1.5%	+49.7%	+59.5%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC